Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidPSA

Providing medicines information to patients

Essential points for quick revision.

Saved on this device

Synopsis

Give prioritised, understandable medicine information that supports safe use, shared decisions and timely action when treatment causes problems.

  • Find out what the person already knows, what they are worried about and who will administer the medicine. Tailor the explanation to the practical decision they face.
  • Explain the purpose, expected benefit, how to take the medicine, the most important safety actions and the review plan. Prioritise information that changes what the patient should do.
  • Use plain language and concrete timings or quantities. Ask the patient to explain the plan back in their own words, framing this as a check of your explanation.

Reasoning priorities

01
Patient explanation of the current regimen

Identify misunderstandings and actual administration habits.

Ask the person to describe a usual treatment day, including food, drinks, supplements and other tablets. Concrete descriptions reveal errors that a yes-or-no adherence question can miss. Check whether old supplies or conflicting labels contribute to the difficulty.

Worked reasoning

Worked exampleBuild a usable weekly alendronic-acid routine

A 66-year-old with osteoporosis is starting alendronic acid 70 mg tablets once weekly. Calcium and renal assessment are satisfactory, there is no dysphagia, and she can remain upright. She chooses Monday and normally drinks coffee and takes calcium tablets at 07:00; she proposes swallowing alendronic acid in bed with that coffee.

  1. Identify the two consequential misunderstandings: the tablet should be taken after getting up with plain water, and coffee or calcium taken simultaneously can interfere with the intended administration. Ask whether moving breakfast and the calcium dose is practical before setting the schedule.
  2. Agree a concrete example: on Monday at 07:00, after rising, swallow one 70 mg tablet whole with at least 200 mL plain water. Remain sitting or standing; do not take it in bed or return to lying down immediately afterwards.
  3. Calculate the minimum separation: 07:00 plus 30 minutes is 07:30. Food, coffee and other oral medicines should wait until at least then, and she should remain upright for at least 30 minutes and until after her first food of the day.
  4. Give the final weekly routine and advise stopping the tablet and seeking prompt medical advice for painful or difficult swallowing, chest pain or new/worsening heartburn. Independently verify the plan by asking her to describe the next Monday morning; the target response includes one weekly tablet, plain water, upright posture and the 07:30 minimum separation.

Key medicines

Alendronic acid 70 mg tabletsOne 70 mg tablet orally once each week on the agreed morning, swallowed whole after rising with at least 200 mL plain water; wait at least 30 minutes before food, other drinks or oral medicines.Stay upright at least 30 minutes and until after first food. Correct hypocalcaemia; avoid oesophageal emptying disorders or inability to remain upright. This product is not recommended below CrCl 35 mL/min; review ongoing treatment need rather than assigning an automatic lifelong course.
Open full textbook Answer 2 questions
Sources and review status5 sources · checked 7 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 7 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom